Nurix Therapeutics
NRIX
$16.59
Share price
7.73%
Change (1 day)
65.73%
Change (1 year)
Categories
Nurix Therapeutics (NRIX) - Cash on Hand
Cash on Hand as of February 2024 : $0.24 B
According to Nurix Therapeutics's latest financial reports the company has $0.24 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nurix Therapeutics - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-11-30 | $0.28 B | -6.87% |
| 2022-11-30 | $0.30 B | 4.54% |
| 2021-11-30 | $0.29 B | 5.18% |
| 2020-11-30 | $0.28 B | 645.36% |
| 2019-11-30 | $37.72 M | -3.38% |
| 2018-11-30 | $39.03 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -14.68% | 🇺🇸 USA |